Article info

Download PDFPDF
Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study

Authors

  1. Correspondence to Domenica Lorusso, Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy; kettalorusso{at}libero.it
View Full Text

Citation

Tripodi E, Cormio G, De Giorgi U, et al
Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study

Publication history

  • Received April 6, 2018
  • Revision received August 30, 2018
  • Accepted September 6, 2018
  • First published January 7, 2019.
Online issue publication 
January 07, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.